Researchers at The University of Queensland have developed a new chimeric virus platform suitable for use in flavivirus vaccine and diagnostic applications.

Key features

  • Chimeras combining an insect-specific flavivirus (ISF) genomic backbone with specific antigenic elements of a vertebrate-infecting flavivirus (VIF)
  • ISF chimeras replicate only in mosquito cells and are expected to be safe to administer to humans and can be prepared with minimal biocontainment
  • Data shows diagnostic and vaccine applications with strong antigenic authenticity
  • ISF chimeras successfully designed to display the antigens from a range of flavivirus pathogens including dengue fever and Zika.
Back to available technologies

Contact us

To enquire about this Available Technology, please contact us.